Annexin Pharmaceuticals (Sweden) Today
| ANNX Stock | SEK 0.50 0.01 1.96% |
Performance0 of 100
| Odds Of DistressOver 68
|
Annexin Pharmaceuticals is selling for under 0.5 as of the 30th of November 2024; that is 1.96 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.48. Annexin Pharmaceuticals has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Annexin Pharmaceuticals AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various cardiovascular diseases. The company was founded in 2014 and is based in Stockholm, Sweden. Annexin Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden.. The company has 154.5 M outstanding shares. More on Annexin Pharmaceuticals AB
Moving against Annexin Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Annexin Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Annexin Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Annexin Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Annexin Pharmaceuticals AB (ANNX) is traded on Stockholm Exchange in Sweden and employs 4 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 189.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Annexin Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Annexin Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Annexin Pharmaceuticals operates under Healthcare sector and is part of Biotechnology industry. The entity has 154.5 M outstanding shares.
Annexin Pharmaceuticals AB has accumulated about 22.77 M in cash with (45.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Annexin Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAnnexin Pharmaceuticals holds a total of 154.5 Million outstanding shares. Annexin Pharmaceuticals AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Annexin Ownership Details
Annexin Pharmaceuticals Risk Profiles
Although Annexin Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Annexin Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.59 | |||
| Standard Deviation | 4.75 | |||
| Variance | 22.54 | |||
| Risk Adjusted Performance | 0.0026 |
Annexin Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Annexin Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Annexin Pharmaceuticals Corporate Management
Elected by the shareholders, the Annexin Pharmaceuticals' board of directors comprises two types of representatives: Annexin Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Annexin. The board's role is to monitor Annexin Pharmaceuticals' management team and ensure that shareholders' interests are well served. Annexin Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Annexin Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ulrika Harndahl | Head CMC | Profile | |
| Anna MD | Chief Officer | Profile | |
| Susan Suchdev | Chief Officer | Profile | |
| Henrik Palm | Chief Officer | Profile | |
| Anders MD | Chief Officer | Profile | |
| MSc LLM | Therapy Ophthalmology | Profile |
Additional Tools for Annexin Stock Analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.